Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Bausch Health Companies Inc. reported revenue of $10.27B, up 6.7% year over year. Operating margin was 17.7% and net margin 1.5%, on a free-cash-flow margin of 9.8% with capital expenditure at 3.9% of revenue. Every figure is computed directly from BHC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $10.27B | 17.7% | 1.5% |
| FY2024 | $9.63B | 16.1% | -0.5% |
| FY2023 | $8.76B | 11.0% | -6.8% |
| FY2022 | $8.12B | 5.6% | -2.8% |
| FY2021 | $8.43B | 5.3% | -11.2% |
How does BHC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.